Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review on the immune responses against novel emerging coronavirus (SARS-CoV-2)
Ramin Lotfi, Rasoul Nasiri Kalmarzi, Seyed Askar Roghani
Immunologic Research (2021) Vol. 69, Iss. 3, pp. 213-224
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 69
Adaptive immunity to SARS-CoV-2 infection: A systematic review
Marcos Jessé Abrahão Silva, Layana Rufino Ribeiro, Karla Valéria Batista Lima, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 48
The influence of COVID-19 infection-associated immune response on the female reproductive system
Mariam Saadedine, Malak El Sabeh, Mostafa A. Borahay, et al.
Biology of Reproduction (2022) Vol. 108, Iss. 2, pp. 172-182
Open Access | Times Cited: 28
Heterogeneity of the Immunological and Pathogenic Profiles in Patients Hospitalize Early Versus Late During an Acute Vital Illness as Shown in Native SARS-CoV-2 Infection
Krzysztof Laudański, Ahmed Sayed Ahmed, Mohamed A. Mahmoud, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2349-2349
Open Access
Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review
Zhangkai J. Cheng, Mingshan Xue, Peiyan Zheng, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 869-869
Open Access | Times Cited: 24
Publication trends of research on COVID-19 and host immune response: A bibliometric analysis
Yun Xia, Ren-qi Yao, Peng-yue Zhao, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 17
Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination
Letizia Scola, Donatella Ferraro, Giuseppa Luisa Sanfilippo, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 413-413
Open Access | Times Cited: 7
SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil
Karoline Rodrigues Campos, Cláudio Tavares Sacchi, Adriano Abbud, et al.
Revista Panamericana de Salud Pública (2021) Vol. 45, pp. 1-1
Open Access | Times Cited: 17
Catalase Activity of IgGs of Patients Infected with SARS-CoV-2
Anna S. Tolmacheva, Margarita K. Onvumere, Sergey E. Sedykh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10081-10081
Open Access | Times Cited: 6
Natural Amphibian-Derived Host Defense Peptides: Peptide Immunomodulators with Potential Therapeutic Value
Jie Shi, Jing Wu, Guizhu Feng, et al.
Protein and Peptide Letters (2023) Vol. 30, Iss. 7, pp. 562-573
Closed Access | Times Cited: 5
Complement inhibition: A possible therapeutic approach in the fight against Covid‐19
Niloofar Deravi, Elahe Ahsan, Mobina Fathi, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Closed Access | Times Cited: 13
SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome
Emanuela Galliera, Luca Massaccesi, Lina Yu, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 826-826
Open Access | Times Cited: 8
Localized delivery of nanomedicine and antibodies for combating COVID-19
Bin Tu, Yanrong Gao, Xinran An, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1828-1846
Open Access | Times Cited: 8
COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses
Jia Yi, Jiameng Miao, Qingwei Zuo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
SARS-CoV-2 and HIV-1: So Different yet so Alike. Immune Response at the Cellular and Molecular Level
Catherine Demoliou, Christos Papaneophytou, Vicky Nicolaidou
International Journal of Medical Sciences (2022) Vol. 19, Iss. 12, pp. 1787-1795
Open Access | Times Cited: 7
Expression of innate immune response genes in upper airway samples of SARS-CoV-2 infected patients: A preliminary study
Madhu Chhanda Mohanty, SwapnilYashwant Varose, UnnatiPrashant Sawant, et al.
The Indian Journal of Medical Research (2021) Vol. 153, Iss. 5, pp. 677-677
Open Access | Times Cited: 9
Blood leukocyte transcriptional modules and differentially expressed genes associated with disease severity and age in COVID-19 patients
Sílvia Yumi Bando, Fernanda Bernardi Bertonha, Sandra Elisabete Vieira, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Assessing the gene expression of the adenosine 5′-monophosphate-activated protein kinase (AMPK) and its relation with the IL-6 and IL-10 plasma levels in COVID-19 patients
Shirin Assar, Mohammad Dastbaz, Komail Amini, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 12, pp. 9925-9933
Closed Access | Times Cited: 3
Epidemiological survey of elderly patients diagnosed with COVID-19 at mobile field hospitals
Meimei Wu, Yao Li, He-Qun Jiang, et al.
Technology and Health Care (2024) Vol. 32, Iss. 4, pp. 2243-2250
Closed Access
Evidence of Neutralizing Antibodies Indicating the Cure of PatientsInfected with COVID-19 Within one Month of Infection
Yasir M. Abdulateef, Zainab N. Ayad, Haitham Noaman, et al.
Anti-Infective Agents (2024) Vol. 22, Iss. 4
Closed Access
Elevated Serum Levels of SARS-CoV-2 Anti-Spike S1 RBD IgM, IgG, and IgA in Pfizer-BioNTech Vaccinated, COVID-19 Infected, and COVID-19 Infected after Pfizer-BioNTech Vaccinated Individuals after One Month
Khalid Abdullah, Ahmed Rushdi Abdullah
Journal of Pioneering Medical Science (2024) Vol. 13, Iss. 1, pp. 106-110
Open Access
Antibodies to the Spike Protein Receptor-Binding Domain of SARS-CoV-2 at 4–13 Months after COVID-19
E. A. Kolosova, Olga N. Shaprova, Daniil V. Shanshin, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 4053-4053
Open Access | Times Cited: 3
A BRIEF DESCRIPTION OF COVID-19 PULMONARY VIRAL INFECTION AND REPURPOSING OF DRUGS FOR ITS TREATMENT
Manisha Patel, Rupa Mazumder, KAMAL KANT KAUSHIK, et al.
International Journal of Applied Pharmaceutics (2022), pp. 22-31
Open Access | Times Cited: 3
Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review
Jennifer Ferraro, Allie Reynolds, Sylvia Edoigiawerie, et al.
World Journal of Methodology (2022) Vol. 12, Iss. 6, pp. 465-475
Open Access | Times Cited: 3
Anti-Inflammatory Effects, Protection of Gut Barrier Integrity and Stimulation of Phagocytosis of postbiotic combination ABB C1<sup>®</sup>
María Tintoré, Jordi Cuñé, Václav Větvička, et al.
(2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top